Trials / Conditions / Smouldering Myeloma
Smouldering Myeloma
4 registered clinical trials studyying Smouldering Myeloma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma NCT06762769 | University College, London | Phase 2 |
| Unknown | Biology and Genetics of Smouldering Myeloma NCT05047107 | University College, London | — |
| Active Not Recruiting | Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM NCT03673826 | Stichting Hemato-Oncologie voor Volwassenen Nederland | Phase 2 |
| Completed | The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Los NCT03951220 | Oxford University Hospitals NHS Trust | — |